Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia

Mol Genet Metab. 2008 Sep-Oct;95(1-2):101-3. doi: 10.1016/j.ymgme.2008.05.006. Epub 2008 Jul 2.

Abstract

Prenatal diagnosis (PD) is available to families affected with propionic acidemia (PA), however, it entails a risk of miscarriage. Fetal DNA circulating in maternal blood could allow performing a safe prenatal diagnosis of fetal mutations. Exclusion of the paternal mutation in maternal plasma may avoid conventional PD in cases of recessive disorders such us PA. In this work, we have correctly diagnosed in maternal plasma the status of a fetus at risk of PA for the paternal mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Metabolism, Inborn Errors / blood
  • Amino Acid Metabolism, Inborn Errors / diagnosis*
  • Amino Acid Metabolism, Inborn Errors / genetics*
  • Female
  • Fetal Diseases / blood
  • Fetal Diseases / diagnosis*
  • Fetal Diseases / genetics*
  • Genetic Testing
  • Humans
  • Male
  • Methylmalonyl-CoA Decarboxylase / genetics
  • Methylmalonyl-CoA Decarboxylase / metabolism
  • Mutation*
  • Pregnancy
  • Pregnancy Trimester, First
  • Prenatal Diagnosis*

Substances

  • Methylmalonyl-CoA Decarboxylase